We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Health Exec Eyes Generic Plavix On The Horizon

Law360 (August 4, 2006, 12:00 AM EDT) -- A top health executive stunned analysts with a controversial statement Friday that a generic version of Bristol-Myers Squibb Co. and Sanofi-Aventis’ blockbuster blood-thinner Plavix may hit the U.S. market as soon as this month.

Medco Health Solutions Inc. CEO David Snow told analysts during a conference call: “We are now forecasting that the generic form of Plavix, a blockbuster drug with U.S. [sales] of nearly $2.7 billion, will become available in 2006."

The comments sent shares of Bristol-Myers and French drug maker Sanofi-Aventis spiraling downward by...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.